Published in Cardiovascular Business Week, April 26th, 2005
The net loss for the quarter was $3.3 million or ($0.09) per share, compared to a net loss of $1.6 million or ($0.06) per share for the same period in 2003.
The company reported a net loss for the year ended December 31, 2004, of $15.9 million or ($0.48) per share, compared to a net loss of $7.5 million or ($0.30) per share for the year ended 2003. The comparative differences were largely the result of a gain on the retirement of company debt and the selling of certain investment assets in 2003. The company had...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.